Unremarkable impact of Oatp inhibition on the liver concentration of fluvastatin, lovastatin and pitavastatin in wild-type and Oatp1a/1b knockout mouse

Xenobiotica; the Fate of Foreign Compounds in Biological Systems
Jae H ChangJustin Ly

Abstract

1. Oatp inhibitors have been shown to significantly increase the plasma exposure of statins. However, understanding alterations of liver concentration is also important. While modeling has simulated liver concentration changes, availability of experimental data is limited, especially when concerning drug-drug interactions (DDI). The objective of this work was to determine blood and liver concentrations of fluvastatin, lovastatin and pitavastatin, when blocking uptake transporters. 2. In wild-type mouse, rifampin pre-treatment decreased the unbound liver-to-plasma ratio (Kp,uu) of fluvastatin by 4.2-fold to 2.2, lovastatin by 4.9-fold to 0.81 and pitavastatin by 10-fold to 0.21. Changes in Kp,uu were driven by increases in systemic exposures as liver concentrations were not greatly altered. 3. In Oatp1a/1b knockout mouse (KO), rifampin exerted no additional effect on fluvastatin and lovastatin. Contrarily, rifampin further decreased pitavastatin Kp,uu by 3.4-fold, suggesting that the KO is inadequate to completely block liver uptake of pitavastatin as there are additional rifampin-sensitive uptake mechanism(s) not captured in the KO model. 4. This work provides experimental data showing that the plasma compartment is more sensit...Continue Reading

References

Jul 1, 1992·Journal of Clinical Pharmacology·F L TseA Troendle
Jun 28, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K FattingerB Stieger
Nov 4, 2000·Expert Opinion on Investigational Drugs·K KajinamiY Saito
May 26, 2004·The Journal of Pharmacology and Experimental Therapeutics·Masaru HiranoYuichi Sugiyama
Nov 19, 2004·Drug Metabolism and Pharmacokinetics·Rieko Tachibana-IimoriTetsuro Miki
Aug 17, 2005·The Pharmacogenomics Journal·J F ThompsonW J Sasiela
Apr 6, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Masaru HiranoYuichi Sugiyama
May 9, 2006·Clinical Pharmacology and Therapeutics·Michael IgelKari T Kivistö
Oct 4, 2006·Clinical Pharmacology and Therapeutics·Mikko NiemiPertti J Neuvonen
Nov 17, 2006·Pharmacogenetics and Genomics·Marja K PasanenMikko Niemi
Dec 29, 2006·Clinical Pharmacology and Therapeutics·Y Y LauL Z Benet
Nov 13, 2008·The Journal of Pharmacology and Experimental Therapeutics·Takao WatanabeYuichi Sugiyama
Nov 22, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Maciej J Zamek-GliszczynskiKim L R Brouwer
Oct 31, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Takao WatanabeYuichi Sugiyama
Jul 21, 2012·Molecular Pharmaceutics·Dilek IusufAlfred H Schinkel
Apr 13, 2013·Current Topics in Medicinal Chemistry·Meihua TuSpiros Liras
Mar 13, 2014·British Journal of Clinical Pharmacology·Thomayant PrueksaritanontS Aubrey Stoch
Mar 29, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jae H ChangJonathan Cheong
May 24, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Laurent SalphatiNico Scheer
Feb 5, 2015·Bioorganic & Medicinal Chemistry Letters·Jingye ZhouMinmin Wang
Jul 15, 2015·Pharmaceutical Research·Manthena V VarmaAyman F El-Kattan
Dec 20, 2015·Tuberculosis·Lindsey H M Te BrakeJan B Koenderink
Mar 7, 2017·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jenny M PedersenPer Artursson

❮ Previous
Next ❯

Citations

Mar 3, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Mingqing ChenAlex Sparreboom
Aug 20, 2019·The Journal of Pharmacology and Experimental Therapeutics·Michelle L MontonyeJohn D Clarke
Sep 8, 2019·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jae H ChangJodie Pang
Apr 4, 2019·Journal of Medicinal Chemistry·Steven J McKerrallDaniel P Sutherlin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.